...
首页> 外文期刊>Journal of chemotherapy >Comparative antimicrobial spectrum and activity of BMS284756 (T-3811; a desfluoroquinolone) tested against an international collection of staphylococci and enterococci, including in vitro test development and intermethod comparisons.
【24h】

Comparative antimicrobial spectrum and activity of BMS284756 (T-3811; a desfluoroquinolone) tested against an international collection of staphylococci and enterococci, including in vitro test development and intermethod comparisons.

机译:BMS284756(T-3811;脱氟喹诺酮)的抗微生物谱和活性针对国际葡萄球菌和肠球菌的收集进行了测试,包括体外测试开发和方法间比较。

获取原文
获取原文并翻译 | 示例
           

摘要

The study was initiated to determine the in vitro activity and MIC/disk test comparisons of BMS284756, a new des-fluoro(6)-quinolone, against isolates of staphylococci and enterococci from the SENTRY Antimicrobial Surveillance Program, 2000. Isolates were tested by reference broth microdilution and standardized disk diffusion methods. Against 3,789 strains of gram-positive cocci from the SENTRY Program (2000), the BMS284756 MIC90 and percentage susceptible at < or = 2 and < or = 4 microg/ml were: Staphylococcus aureus (4 microg/ml; 89.3 and 97.1%), coagulase-negative staphylococci (CoNS; 4 microg/ml; 86.1 and 96.0%) and enterococci (> 4 microg/ml; 62.0 and 76.2%). Also tested were selected staphylococci (300 strains) and enterococci (102 strains) by two standardized methods. The activity of BMS284756 was highly correlated with oxacillin resistance among staphylococci. Oxacillin-susceptible staphylococci were all inhibited by BMS284756 at < or = 0.5 microg/ml, whereas oxacillin-resistant strains required inhibitory concentrations of > or = 1 microg/ml. Excellent correlation was observed between the MIC and 5-microg disk zone diameter for staphylococci and enterococci (r=0.91 to 0.93). Among vancomycin-susceptible enterococci, 67% of Enterococcus faecalis, 25% of E. faecium, and 76% of other Enterococcus spp. isolates were inhibited by BMS284756 at < or = 2 microg/ml. All vancomycin-resistant enterococci (VRE; 11 E. faecalis and 15 E. faecium) were inhibited by > or = 2 microg/ml of BMS284756. Among the non-VRE, non-faecium enterococcal isolates (n=64), 62% were inhibited by < or = 0.5 microg/ml. BMS284756 showed excellent activity against oxacillin-susceptible staphylococci and moderate activity against enterococci other than VRE and E. faecium. Acceptable correlations were observed between MIC and disk test results for both tested genus groups.
机译:这项研究的开始是为了确定BMS284756(一种新型的去氟(6)-喹诺酮)针对来自SENTRY Antimicrobial Surveillance Program,2000年的葡萄球菌和肠球菌分离株的体外活性和MIC /磁盘测试比较。肉汤微稀释和标准化圆盘扩散方法。针对来自SENTRY程序(2000)的3,789株革兰氏阳性球菌,BMS284756 MIC90和敏感度在<或= 2和<或= 4 microg / ml的百分比为:金黄色葡萄球菌(4 microg / ml; 89.3和97.1%) ,凝固酶阴性葡萄球菌(CoNS; 4 microg / ml; 86.1和96.0%)和肠球菌(> 4 microg / ml; 62.0和76.2%)。还通过两种标准化方法选择了葡萄球菌(300株)和肠球菌(102株)。 BMS284756的活性与葡萄球菌中的奥沙西林耐药性高度相关。 BMS284756均以<或= 0.5 microg / ml抑制奥沙西林敏感性葡萄球菌,而耐奥沙西林的菌株要求抑制浓度为>或= 1 microg / ml。观察到葡萄球菌和肠球菌的MIC和5微克圆盘区直径之间具有极好的相关性(r = 0.91至0.93)。在对万古霉素敏感的肠球菌中,粪肠球菌占67%,粪肠球菌占25%,其他肠球菌属占76%。 BMS284756将分离出的分离物抑制为<或= 2 microg / ml。 ≥2 microg / ml的BMS284756抑制所有耐万古霉素的肠球菌(VRE;粪肠杆菌11和粪便15)。在非VRE,非粪肠球菌分离物中(n = 64),≤0.5 microg / ml抑制了62%。 BMS284756表现出优异的抗草酸敏感性葡萄球菌活性,并具有中等抵抗VRE和粪肠球菌的肠球菌活性。对于两个测试属组,在MIC和磁盘测试结果之间都观察到了可接受的相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号